Pharaoh Neuro has developed a novel device to remove blood and blood-borne toxins from the cerebrospinal fluid in patients suffering from subarachnoid hemorrhage and other CSF-related pathologies.
Pharaoh Neuro Secures $20 Million Series A and Appoints CEO and CMO to Advance Neurapheresis™ Platform
Pharaoh Neuro, Inc., a medical device company developing innovative solutions for neurocritical care, today announced the closing of an oversubscribed $20 million Series A financing and the appointments of Amaza…
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.
